Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Abeona Therapeutics Inc.
Type
Public
Industry Biomedicine
Founded Dallas, Texas 1989 (1989)
Headquarters United States
Website http://abeonatherapeutics.com/

Abeona Therapeutics, Inc. is a pharmaceutical development company. Its research focuses on developing treatments for rare diseases using gene therapy and human plasma-derived therapeutics. The company is trying to find ways to address Sanfilippo Syndrome, Fanconi anemia, and Juvenile Batten disease. It has stated it anticipates starting clinical trials on an adeno-associated virus-based gene therapy for Sanfilippo syndrome in 2015.

Abeona also is developing a salt diafiltration process for purifying proteins from blood plasma and a polymer hydrogel for delivering drugs.

The company was formerly known as Access Pharmaceuticals. It was based in Dallas and was incorporated in 1989. In late 2014 the company changed its name to PlasmaTech Biopharmaceuticals. In 2015 PlasmaTech acquired a company based in Cleveland called Abeona Therapeutics which was founded in 2013. In June 2015 the parent company adopted the name Abeona Therapeutics.

The name Abeona comes from a Roman goddess who was said to protect children. The company's stock is traded on NASDAQ under the symbol ABEO.

Investment goal date:
Dividends reinvested
Abeona Therapeutics Inc. ABEO report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-03-20
--
--
Q2 2017
2017-11-13
--
--
Q3 2017
2017-11-09
--
--
Q2 2017
2017-08-14
-0.2100
-0.2100
Q1 2017
2017-05-15
-0.1300
-0.1300
Q4 2016
2017-03-30
-0.1900
-0.1800
Q3 2016
2016-11-10
-0.0800
-0.0800
Q2 2016
2016-08-15
-0.2000
-0.2000
Q1 2016
2016-05-16
-0.1700
-0.1700
Q4 2015
2016-03-08
-0.0700
-0.0700
Q3 2015
2015-11-17
-0.1900
-0.1900
Q2 2015
2015-08-14
-0.1600
-0.1600
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Major Shareholders
Name Relationship
Total Shares
Holding stocks